TP53 and acute myeloid leukemia: The p53 agonist nutlin was combined with VPA, and the two drugs caused a synergistic induction of p53-dependent apoptosis in AML cell lines and primary AML cells. This synergism was also demonstrated in xenograft models of human AML.